Abstract | PURPOSE: MATERIALS AND METHODS: One hundred and thirty-two hypertensive elderly patients (>60 years) were enrolled in this study, and assigned into either the cognitive impairment group (n=61) or the normal cognitive group (n=71). Gender, age, education, body mass index (BMI), waist hip ratio (WHR), total cholesterol (TC), triglyceride (TG), C-reactive protein (CRP), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol ( LDL-C), creatinine (Cr), fasting plasma glucose (FPG), fasting insulin (FINS), homeostasis model of assessment for insulin resistance index (HOMA-IR), systolic blood pressure, diastolic blood pressure, smoking history, atherosclerosis and the proportion of uncontrolled hypertension were compared between the two groups. Multi-factorial logistic regression analysis was performed. RESULTS: No significant differences were found in gender, age, TC, CRP, HDL-C, LDL-C, Cr, BP, smoking history, atherosclerosis and the proportion of uncontrolled hypertension between the two groups. The cognitive impairment group had lower education levels, and higher BMI, WHR, TG, FPG, FINS, and HOMA-IR levels than the control group. Logistic regression analysis revealed the levels of education, BMI, WHR, and HOMA-IR as independent factors that predict cognitive impairment in patients. CONCLUSION:
|
Authors | Lina Ma, Ming Feng, Yuying Qian, Wei Yang, Jia Liu, Rui Han, Hong Zhu, Yun Li |
Journal | Yonsei medical journal
(Yonsei Med J)
Vol. 56
Issue 1
Pg. 89-94
(Jan 2015)
ISSN: 1976-2437 [Electronic] Korea (South) |
PMID | 25510751
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Aged
- Case-Control Studies
- Cognition Disorders
(etiology)
- Essential Hypertension
- Female
- Humans
- Hypertension
(complications)
- Insulin Resistance
- Logistic Models
- Male
- Risk Factors
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|